nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—Migraine—Ursodeoxycholic acid—primary biliary cirrhosis	0.00373	0.00405	CcSEcCtD
Duloxetine—Migraine—Chenodeoxycholic acid—primary biliary cirrhosis	0.00373	0.00405	CcSEcCtD
Duloxetine—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00372	0.00404	CcSEcCtD
Duloxetine—Muscular weakness—Colchicine—primary biliary cirrhosis	0.00372	0.00404	CcSEcCtD
Duloxetine—Face oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00366	0.00398	CcSEcCtD
Duloxetine—Face oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00366	0.00398	CcSEcCtD
Duloxetine—Blood creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00355	0.00386	CcSEcCtD
Duloxetine—Blood creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00355	0.00386	CcSEcCtD
Duloxetine—Dehydration—Ursodeoxycholic acid—primary biliary cirrhosis	0.00353	0.00383	CcSEcCtD
Duloxetine—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.00353	0.00383	CcSEcCtD
Duloxetine—Liver function test abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.0035	0.0038	CcSEcCtD
Duloxetine—Liver function test abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.0035	0.0038	CcSEcCtD
Duloxetine—Abdominal discomfort—Colchicine—primary biliary cirrhosis	0.0035	0.0038	CcSEcCtD
Duloxetine—Abdominal pain upper—Ursodeoxycholic acid—primary biliary cirrhosis	0.00346	0.00376	CcSEcCtD
Duloxetine—Abdominal pain upper—Chenodeoxycholic acid—primary biliary cirrhosis	0.00346	0.00376	CcSEcCtD
Duloxetine—Orthostatic hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00346	0.00376	CcSEcCtD
Duloxetine—Orthostatic hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00346	0.00376	CcSEcCtD
Duloxetine—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00343	0.00372	CcSEcCtD
Duloxetine—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00343	0.00372	CcSEcCtD
Duloxetine—Cramp muscle—Chenodeoxycholic acid—primary biliary cirrhosis	0.00341	0.00371	CcSEcCtD
Duloxetine—Aspartate aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00341	0.00371	CcSEcCtD
Duloxetine—Cramp muscle—Ursodeoxycholic acid—primary biliary cirrhosis	0.00341	0.00371	CcSEcCtD
Duloxetine—Aspartate aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00341	0.00371	CcSEcCtD
Duloxetine—Gastritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00335	0.00364	CcSEcCtD
Duloxetine—Gastritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00335	0.00364	CcSEcCtD
Duloxetine—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00334	0.00363	CcSEcCtD
Duloxetine—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00334	0.00363	CcSEcCtD
Duloxetine—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.00328	0.00356	CcSEcCtD
Duloxetine—Dysphagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00328	0.00356	CcSEcCtD
Duloxetine—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.00328	0.00356	CcSEcCtD
Duloxetine—Dysphagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00328	0.00356	CcSEcCtD
Duloxetine—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00321	0.00349	CcSEcCtD
Duloxetine—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00321	0.00349	CcSEcCtD
Duloxetine—Stomatitis—Colchicine—primary biliary cirrhosis	0.00317	0.00344	CcSEcCtD
Duloxetine—Abdominal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00314	0.00341	CcSEcCtD
Duloxetine—Abdominal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00314	0.00341	CcSEcCtD
Duloxetine—Dysuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00306	0.00333	CcSEcCtD
Duloxetine—Dysuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00306	0.00333	CcSEcCtD
Duloxetine—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00304	0.00331	CcSEcCtD
Duloxetine—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00304	0.00331	CcSEcCtD
Duloxetine—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00303	0.00329	CcSEcCtD
Duloxetine—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00303	0.00329	CcSEcCtD
Duloxetine—Photosensitivity reaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00299	0.00325	CcSEcCtD
Duloxetine—Photosensitivity reaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00299	0.00325	CcSEcCtD
Duloxetine—Weight increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00298	0.00324	CcSEcCtD
Duloxetine—Weight increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00298	0.00324	CcSEcCtD
Duloxetine—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00296	0.00322	CcSEcCtD
Duloxetine—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00296	0.00322	CcSEcCtD
Duloxetine—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00292	0.00317	CcSEcCtD
Duloxetine—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.00292	0.00317	CcSEcCtD
Duloxetine—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.00292	0.00317	CcSEcCtD
Duloxetine—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00292	0.00317	CcSEcCtD
Duloxetine—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.0029	0.00315	CcSEcCtD
Duloxetine—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.00288	0.00313	CcSEcCtD
Duloxetine—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.00288	0.00313	CcSEcCtD
Duloxetine—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.00287	0.00312	CcSEcCtD
Duloxetine—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.00287	0.00312	CcSEcCtD
Duloxetine—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00286	0.00311	CcSEcCtD
Duloxetine—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00286	0.00311	CcSEcCtD
Duloxetine—Jaundice—Chenodeoxycholic acid—primary biliary cirrhosis	0.00285	0.00309	CcSEcCtD
Duloxetine—Jaundice—Ursodeoxycholic acid—primary biliary cirrhosis	0.00285	0.00309	CcSEcCtD
Duloxetine—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00284	0.00308	CcSEcCtD
Duloxetine—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00284	0.00308	CcSEcCtD
Duloxetine—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00284	0.00308	CcSEcCtD
Duloxetine—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00284	0.00308	CcSEcCtD
Duloxetine—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.00276	0.003	CcSEcCtD
Duloxetine—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.00276	0.003	CcSEcCtD
Duloxetine—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00276	0.00299	CcSEcCtD
Duloxetine—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00276	0.00299	CcSEcCtD
Duloxetine—Eye disorder—Colchicine—primary biliary cirrhosis	0.00273	0.00296	CcSEcCtD
Duloxetine—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.00264	0.00286	CcSEcCtD
Duloxetine—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.00264	0.00286	CcSEcCtD
Duloxetine—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00263	0.00286	CcSEcCtD
Duloxetine—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.00262	0.00285	CcSEcCtD
Duloxetine—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.00262	0.00285	CcSEcCtD
Duloxetine—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.0026	0.00283	CcSEcCtD
Duloxetine—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.0026	0.00283	CcSEcCtD
Duloxetine—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00259	0.00281	CcSEcCtD
Duloxetine—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00259	0.00281	CcSEcCtD
Duloxetine—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.00258	0.00281	CcSEcCtD
Duloxetine—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.00258	0.00281	CcSEcCtD
Duloxetine—Alopecia—Colchicine—primary biliary cirrhosis	0.00258	0.0028	CcSEcCtD
Duloxetine—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00258	0.0028	CcSEcCtD
Duloxetine—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00258	0.0028	CcSEcCtD
Duloxetine—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00257	0.00279	CcSEcCtD
Duloxetine—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00257	0.00279	CcSEcCtD
Duloxetine—Malnutrition—Colchicine—primary biliary cirrhosis	0.00254	0.00276	CcSEcCtD
Duloxetine—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.00253	0.00275	CcSEcCtD
Duloxetine—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.00253	0.00275	CcSEcCtD
Duloxetine—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00245	0.00266	CcSEcCtD
Duloxetine—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00245	0.00266	CcSEcCtD
Duloxetine—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00244	0.00266	CcSEcCtD
Duloxetine—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00244	0.00266	CcSEcCtD
Duloxetine—Muscle spasms—Colchicine—primary biliary cirrhosis	0.00244	0.00265	CcSEcCtD
Duloxetine—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00243	0.00264	CcSEcCtD
Duloxetine—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00243	0.00264	CcSEcCtD
Duloxetine—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00238	0.00258	CcSEcCtD
Duloxetine—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00238	0.00258	CcSEcCtD
Duloxetine—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00237	0.00257	CcSEcCtD
Duloxetine—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00237	0.00257	CcSEcCtD
Duloxetine—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00236	0.00257	CcSEcCtD
Duloxetine—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00236	0.00257	CcSEcCtD
Duloxetine—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.00235	0.00256	CcSEcCtD
Duloxetine—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.00235	0.00256	CcSEcCtD
Duloxetine—Anaemia—Colchicine—primary biliary cirrhosis	0.00235	0.00255	CcSEcCtD
Duloxetine—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00234	0.00254	CcSEcCtD
Duloxetine—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00234	0.00254	CcSEcCtD
Duloxetine—Angioedema—Colchicine—primary biliary cirrhosis	0.00232	0.00252	CcSEcCtD
Duloxetine—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00232	0.00252	CcSEcCtD
Duloxetine—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00232	0.00252	CcSEcCtD
Duloxetine—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.00228	0.00248	CcSEcCtD
Duloxetine—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.00228	0.00248	CcSEcCtD
Duloxetine—Leukopenia—Colchicine—primary biliary cirrhosis	0.00227	0.00247	CcSEcCtD
Duloxetine—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00225	0.00244	CcSEcCtD
Duloxetine—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00225	0.00244	CcSEcCtD
Duloxetine—Tension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00224	0.00243	CcSEcCtD
Duloxetine—Tension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00224	0.00243	CcSEcCtD
Duloxetine—Nervousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00222	0.00241	CcSEcCtD
Duloxetine—Nervousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00222	0.00241	CcSEcCtD
Duloxetine—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00221	0.0024	CcSEcCtD
Duloxetine—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00221	0.0024	CcSEcCtD
Duloxetine—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.00219	0.00238	CcSEcCtD
Duloxetine—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.00219	0.00238	CcSEcCtD
Duloxetine—Myalgia—Colchicine—primary biliary cirrhosis	0.00216	0.00235	CcSEcCtD
Duloxetine—Arthralgia—Colchicine—primary biliary cirrhosis	0.00216	0.00235	CcSEcCtD
Duloxetine—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00212	0.0023	CcSEcCtD
Duloxetine—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00212	0.0023	CcSEcCtD
Duloxetine—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00211	0.00229	CcSEcCtD
Duloxetine—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00211	0.00229	CcSEcCtD
Duloxetine—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00209	0.00227	CcSEcCtD
Duloxetine—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00209	0.00227	CcSEcCtD
Duloxetine—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.00206	0.00224	CcSEcCtD
Duloxetine—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.00206	0.00224	CcSEcCtD
Duloxetine—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.00205	0.00223	CcSEcCtD
Duloxetine—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.00205	0.00223	CcSEcCtD
Duloxetine—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.00205	0.00222	CcSEcCtD
Duloxetine—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.00205	0.00222	CcSEcCtD
Duloxetine—Leukopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00204	0.00222	CcSEcCtD
Duloxetine—Leukopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00204	0.00222	CcSEcCtD
Duloxetine—Shock—Colchicine—primary biliary cirrhosis	0.00204	0.00222	CcSEcCtD
Duloxetine—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.00203	0.00221	CcSEcCtD
Duloxetine—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.00203	0.00221	CcSEcCtD
Duloxetine—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.00202	0.00219	CcSEcCtD
Duloxetine—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.00202	0.00219	CcSEcCtD
Duloxetine—Skin disorder—Colchicine—primary biliary cirrhosis	0.00201	0.00219	CcSEcCtD
Duloxetine—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00201	0.00218	CcSEcCtD
Duloxetine—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00201	0.00218	CcSEcCtD
Duloxetine—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.00199	0.00216	CcSEcCtD
Duloxetine—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.00199	0.00216	CcSEcCtD
Duloxetine—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.00198	0.00215	CcSEcCtD
Duloxetine—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.00198	0.00215	CcSEcCtD
Duloxetine—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00197	0.00214	CcSEcCtD
Duloxetine—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00197	0.00214	CcSEcCtD
Duloxetine—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00194	0.00211	CcSEcCtD
Duloxetine—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00194	0.00211	CcSEcCtD
Duloxetine—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00194	0.00211	CcSEcCtD
Duloxetine—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00194	0.00211	CcSEcCtD
Duloxetine—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00194	0.00211	CcSEcCtD
Duloxetine—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00194	0.00211	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00193	0.0021	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00193	0.0021	CcSEcCtD
Duloxetine—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00192	0.00209	CcSEcCtD
Duloxetine—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00192	0.00209	CcSEcCtD
Duloxetine—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.0019	0.00206	CcSEcCtD
Duloxetine—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.0019	0.00206	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.00189	0.00205	CcSEcCtD
Duloxetine—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.00188	0.00204	CcSEcCtD
Duloxetine—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.00188	0.00204	CcSEcCtD
Duloxetine—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00186	0.00202	CcSEcCtD
Duloxetine—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00186	0.00202	CcSEcCtD
Duloxetine—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00185	0.00201	CcSEcCtD
Duloxetine—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00185	0.00201	CcSEcCtD
Duloxetine—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.00183	0.00199	CcSEcCtD
Duloxetine—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.00183	0.00199	CcSEcCtD
Duloxetine—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00183	0.00198	CcSEcCtD
Duloxetine—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00183	0.00198	CcSEcCtD
Duloxetine—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00182	0.00198	CcSEcCtD
Duloxetine—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00182	0.00198	CcSEcCtD
Duloxetine—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00182	0.00198	CcSEcCtD
Duloxetine—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00182	0.00198	CcSEcCtD
Duloxetine—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00181	0.00197	CcSEcCtD
Duloxetine—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00181	0.00197	CcSEcCtD
Duloxetine—Decreased appetite—Colchicine—primary biliary cirrhosis	0.0018	0.00196	CcSEcCtD
Duloxetine—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.0018	0.00196	CcSEcCtD
Duloxetine—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.0018	0.00196	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.00179	0.00194	CcSEcCtD
Duloxetine—Fatigue—Colchicine—primary biliary cirrhosis	0.00179	0.00194	CcSEcCtD
Duloxetine—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00178	0.00193	CcSEcCtD
Duloxetine—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00178	0.00193	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.0017	0.00184	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.0017	0.00184	CcSEcCtD
Duloxetine—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.0017	0.00184	CcSEcCtD
Duloxetine—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00169	0.00183	CcSEcCtD
Duloxetine—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00169	0.00183	CcSEcCtD
Duloxetine—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00167	0.00182	CcSEcCtD
Duloxetine—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00167	0.00182	CcSEcCtD
Duloxetine—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00166	0.0018	CcSEcCtD
Duloxetine—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00166	0.0018	CcSEcCtD
Duloxetine—Urticaria—Colchicine—primary biliary cirrhosis	0.00165	0.00179	CcSEcCtD
Duloxetine—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00178	CcSEcCtD
Duloxetine—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00178	CcSEcCtD
Duloxetine—Abdominal pain—Colchicine—primary biliary cirrhosis	0.00164	0.00178	CcSEcCtD
Duloxetine—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00176	CcSEcCtD
Duloxetine—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00176	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00161	0.00175	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00161	0.00175	CcSEcCtD
Duloxetine—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00161	0.00174	CcSEcCtD
Duloxetine—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00161	0.00174	CcSEcCtD
Duloxetine—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00159	0.00173	CcSEcCtD
Duloxetine—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00159	0.00173	CcSEcCtD
Duloxetine—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00159	0.00173	CcSEcCtD
Duloxetine—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00159	0.00173	CcSEcCtD
Duloxetine—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00167	CcSEcCtD
Duloxetine—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00167	CcSEcCtD
Duloxetine—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.00153	0.00166	CcSEcCtD
Duloxetine—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00152	0.00165	CcSEcCtD
Duloxetine—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00152	0.00165	CcSEcCtD
Duloxetine—Asthenia—Colchicine—primary biliary cirrhosis	0.00149	0.00162	CcSEcCtD
Duloxetine—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00148	0.00161	CcSEcCtD
Duloxetine—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00148	0.00161	CcSEcCtD
Duloxetine—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00147	0.0016	CcSEcCtD
Duloxetine—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00147	0.0016	CcSEcCtD
Duloxetine—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00147	0.0016	CcSEcCtD
Duloxetine—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00147	0.0016	CcSEcCtD
Duloxetine—Diarrhoea—Colchicine—primary biliary cirrhosis	0.00142	0.00154	CcSEcCtD
Duloxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.00141	0.0177	CbGpPWpGaD
Duloxetine—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00149	CcSEcCtD
Duloxetine—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00149	CcSEcCtD
Duloxetine—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00134	0.00145	CcSEcCtD
Duloxetine—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00134	0.00145	CcSEcCtD
Duloxetine—Vomiting—Colchicine—primary biliary cirrhosis	0.00132	0.00143	CcSEcCtD
Duloxetine—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00132	0.00143	CcSEcCtD
Duloxetine—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00132	0.00143	CcSEcCtD
Duloxetine—Rash—Colchicine—primary biliary cirrhosis	0.00131	0.00142	CcSEcCtD
Duloxetine—Dermatitis—Colchicine—primary biliary cirrhosis	0.00131	0.00142	CcSEcCtD
Duloxetine—Headache—Colchicine—primary biliary cirrhosis	0.0013	0.00141	CcSEcCtD
Duloxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.00128	0.0161	CbGpPWpGaD
Duloxetine—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00127	0.00138	CcSEcCtD
Duloxetine—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00127	0.00138	CcSEcCtD
Duloxetine—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00123	0.00134	CcSEcCtD
Duloxetine—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00123	0.00134	CcSEcCtD
Duloxetine—Nausea—Colchicine—primary biliary cirrhosis	0.00123	0.00134	CcSEcCtD
Duloxetine—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.00118	0.00129	CcSEcCtD
Duloxetine—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.00118	0.00129	CcSEcCtD
Duloxetine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.00118	0.0149	CbGpPWpGaD
Duloxetine—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00128	CcSEcCtD
Duloxetine—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00128	CcSEcCtD
Duloxetine—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00127	CcSEcCtD
Duloxetine—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00127	CcSEcCtD
Duloxetine—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00127	CcSEcCtD
Duloxetine—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00127	CcSEcCtD
Duloxetine—SLC6A4—Monoamine Transport—AGT—primary biliary cirrhosis	0.00117	0.0147	CbGpPWpGaD
Duloxetine—CYP1A2—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.00111	0.0139	CbGpPWpGaD
Duloxetine—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00111	0.0012	CcSEcCtD
Duloxetine—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00111	0.0012	CcSEcCtD
Duloxetine—SLC6A2—SLC-mediated transmembrane transport—SLC4A2—primary biliary cirrhosis	0.00109	0.0137	CbGpPWpGaD
Duloxetine—NPY1R—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.00107	0.0135	CbGpPWpGaD
Duloxetine—SLC6A2—Monoamine Transport—AGT—primary biliary cirrhosis	0.001	0.0126	CbGpPWpGaD
Duloxetine—NPY1R—Peptide ligand-binding receptors—CXCL10—primary biliary cirrhosis	0.000994	0.0125	CbGpPWpGaD
Duloxetine—NPY1R—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000974	0.0123	CbGpPWpGaD
Duloxetine—SLC6A3—SLC-mediated transmembrane transport—SLC4A2—primary biliary cirrhosis	0.000965	0.0121	CbGpPWpGaD
Duloxetine—HTR6—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.000909	0.0114	CbGpPWpGaD
Duloxetine—SLC6A3—Monoamine Transport—AGT—primary biliary cirrhosis	0.000888	0.0112	CbGpPWpGaD
Duloxetine—NPY1R—Peptide ligand-binding receptors—CCL5—primary biliary cirrhosis	0.000855	0.0108	CbGpPWpGaD
Duloxetine—NPY1R—G alpha (i) signalling events—CXCL10—primary biliary cirrhosis	0.000838	0.0106	CbGpPWpGaD
Duloxetine—SLC6A4—NRF2 pathway—ABCC2—primary biliary cirrhosis	0.0008	0.0101	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—AQP4—primary biliary cirrhosis	0.000792	0.00997	CbGpPWpGaD
Duloxetine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000776	0.00977	CbGpPWpGaD
Duloxetine—CYP1A2—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000772	0.00971	CbGpPWpGaD
Duloxetine—NPY1R—G alpha (i) signalling events—CCL5—primary biliary cirrhosis	0.000722	0.00908	CbGpPWpGaD
Duloxetine—NPY1R—Peptide ligand-binding receptors—AGT—primary biliary cirrhosis	0.000715	0.00901	CbGpPWpGaD
Duloxetine—SLC6A2—NRF2 pathway—ABCC2—primary biliary cirrhosis	0.000688	0.00866	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—primary biliary cirrhosis	0.000684	0.00861	CbGpPWpGaD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.00067	0.00843	CbGpPWpGaD
Duloxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000666	0.00839	CbGpPWpGaD
Duloxetine—SLC6A3—NRF2 pathway—ABCC2—primary biliary cirrhosis	0.00061	0.00767	CbGpPWpGaD
Duloxetine—HTR6—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.000607	0.00764	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000606	0.00763	CbGpPWpGaD
Duloxetine—NPY1R—G alpha (i) signalling events—AGT—primary biliary cirrhosis	0.000604	0.0076	CbGpPWpGaD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.000581	0.00732	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IGFBP1—primary biliary cirrhosis	0.000581	0.00732	CbGpPWpGaD
Duloxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000574	0.00722	CbGpPWpGaD
Duloxetine—SLC6A2—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000554	0.00697	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000551	0.00693	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000551	0.00693	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.00052	0.00654	CbGpPWpGaD
Duloxetine—NPY1R—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000507	0.00639	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.0005	0.0063	CbGpPWpGaD
Duloxetine—SLC6A4—NRF2 pathway—GGT1—primary biliary cirrhosis	0.000499	0.00629	CbGpPWpGaD
Duloxetine—SLC6A3—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.00049	0.00617	CbGpPWpGaD
Duloxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.00048	0.00604	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—AQP4—primary biliary cirrhosis	0.000476	0.006	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000472	0.00594	CbGpPWpGaD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.000447	0.00562	CbGpPWpGaD
Duloxetine—NPY1R—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000437	0.0055	CbGpPWpGaD
Duloxetine—SLC6A2—NRF2 pathway—GGT1—primary biliary cirrhosis	0.000429	0.00541	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—primary biliary cirrhosis	0.000429	0.00541	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—PPARGC1A—primary biliary cirrhosis	0.000421	0.00531	CbGpPWpGaD
Duloxetine—SLC6A2—SLC-mediated transmembrane transport—NUP210—primary biliary cirrhosis	0.000397	0.00499	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000396	0.00498	CbGpPWpGaD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.000388	0.00488	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000383	0.00482	CbGpPWpGaD
Duloxetine—SLC6A3—NRF2 pathway—GGT1—primary biliary cirrhosis	0.00038	0.00479	CbGpPWpGaD
Duloxetine—NPY1R—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000365	0.0046	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000359	0.00452	CbGpPWpGaD
Duloxetine—CYP1A2—Arachidonic acid metabolism—GGT1—primary biliary cirrhosis	0.000356	0.00448	CbGpPWpGaD
Duloxetine—SLC6A3—SLC-mediated transmembrane transport—NUP210—primary biliary cirrhosis	0.000351	0.00442	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000348	0.00438	CbGpPWpGaD
Duloxetine—SLC6A4—Circadian rythm related genes—PPARGC1A—primary biliary cirrhosis	0.000344	0.00433	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000338	0.00425	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000332	0.00418	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—HIF1A—primary biliary cirrhosis	0.00033	0.00415	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000325	0.0041	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000302	0.0038	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000295	0.00372	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000291	0.00367	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000287	0.00361	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000273	0.00344	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000265	0.00333	CbGpPWpGaD
Duloxetine—CYP2D6—Melatonin metabolism and effects—NFKB1—primary biliary cirrhosis	0.000262	0.0033	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.00026	0.00328	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—PPARGC1A—primary biliary cirrhosis	0.000254	0.00319	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000253	0.00319	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000247	0.00311	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000246	0.0031	CbGpPWpGaD
Duloxetine—SLC6A4—Circadian rythm related genes—NOS2—primary biliary cirrhosis	0.000245	0.00308	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000238	0.00299	CbGpPWpGaD
Duloxetine—SLC6A2—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.00023	0.00289	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.00023	0.00289	CbGpPWpGaD
Duloxetine—CYP1A2—Phase II conjugation—GGT1—primary biliary cirrhosis	0.000226	0.00285	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000224	0.00282	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000224	0.00282	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	0.000223	0.00281	CbGpPWpGaD
Duloxetine—CYP1A2—Melatonin metabolism and effects—NFKB1—primary biliary cirrhosis	0.000222	0.0028	CbGpPWpGaD
Duloxetine—SLC6A2—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.00022	0.00277	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000212	0.00266	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—AGT—primary biliary cirrhosis	0.000207	0.0026	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000205	0.00258	CbGpPWpGaD
Duloxetine—SLC6A3—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.000204	0.00256	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000203	0.00256	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000203	0.00256	CbGpPWpGaD
Duloxetine—SLC6A2—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000202	0.00254	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—HIF1A—primary biliary cirrhosis	0.000198	0.0025	CbGpPWpGaD
Duloxetine—HTR2C—G alpha (q) signalling events—AGT—primary biliary cirrhosis	0.000197	0.00248	CbGpPWpGaD
Duloxetine—SLC6A3—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.000195	0.00246	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	0.000194	0.00244	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—NFKB1—primary biliary cirrhosis	0.000191	0.00241	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—AGT—primary biliary cirrhosis	0.000188	0.00236	CbGpPWpGaD
Duloxetine—SLC6A2—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	0.000187	0.00236	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000187	0.00236	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000184	0.00232	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000181	0.00228	CbGpPWpGaD
Duloxetine—SLC6A3—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000179	0.00225	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000177	0.00223	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	0.000176	0.00222	CbGpPWpGaD
Duloxetine—HTR2A—G alpha (q) signalling events—AGT—primary biliary cirrhosis	0.000171	0.00215	CbGpPWpGaD
Duloxetine—SLC6A3—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	0.000166	0.00209	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000165	0.00207	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000161	0.00203	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000157	0.00198	CbGpPWpGaD
Duloxetine—CYP2D6—Biological oxidations—GGT1—primary biliary cirrhosis	0.000156	0.00197	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000156	0.00196	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CXCL10—primary biliary cirrhosis	0.000154	0.00194	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—primary biliary cirrhosis	0.000154	0.00193	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	0.000153	0.00192	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.00015	0.00188	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.00015	0.00188	CbGpPWpGaD
Duloxetine—SLC6A2—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	0.000144	0.00181	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000143	0.0018	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—MMP3—primary biliary cirrhosis	0.00014	0.00177	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—TYK2—primary biliary cirrhosis	0.00014	0.00177	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000138	0.00174	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000136	0.00171	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000135	0.0017	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000135	0.0017	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CCL5—primary biliary cirrhosis	0.000132	0.00167	CbGpPWpGaD
Duloxetine—CYP1A2—Biological oxidations—GGT1—primary biliary cirrhosis	0.000132	0.00167	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	0.000132	0.00166	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.00013	0.00164	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.00013	0.00164	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.00013	0.00164	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	0.000128	0.00162	CbGpPWpGaD
Duloxetine—SLC6A3—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	0.000128	0.00161	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000125	0.00157	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.000124	0.00156	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.00012	0.00151	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.00012	0.00151	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000119	0.00149	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000118	0.00148	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—NFKB1—primary biliary cirrhosis	0.000115	0.00145	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	0.000114	0.00144	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000113	0.00143	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—HIF1A—primary biliary cirrhosis	0.000111	0.0014	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—AGT—primary biliary cirrhosis	0.000111	0.00139	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000109	0.00137	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—LBR—primary biliary cirrhosis	0.000108	0.00135	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000106	0.00133	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000103	0.0013	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000101	0.00127	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—AGT—primary biliary cirrhosis	9.93e-05	0.00125	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CD80—primary biliary cirrhosis	9.81e-05	0.00124	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CXCL10—primary biliary cirrhosis	9.61e-05	0.00121	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CDH5—primary biliary cirrhosis	9.18e-05	0.00116	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—LBR—primary biliary cirrhosis	9.11e-05	0.00115	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CCL5—primary biliary cirrhosis	9.11e-05	0.00115	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CXCR5—primary biliary cirrhosis	8.84e-05	0.00111	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—MMP3—primary biliary cirrhosis	8.76e-05	0.0011	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—AGT—primary biliary cirrhosis	8.62e-05	0.00109	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—TYK2—primary biliary cirrhosis	8.28e-05	0.00104	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CCL5—primary biliary cirrhosis	8.27e-05	0.00104	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CXCL9—primary biliary cirrhosis	8.02e-05	0.00101	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CDH5—primary biliary cirrhosis	7.97e-05	0.001	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	7.79e-05	0.000981	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—OGDH—primary biliary cirrhosis	7.78e-05	0.000979	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CXCR5—primary biliary cirrhosis	7.67e-05	0.000966	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—AGT—primary biliary cirrhosis	7.62e-05	0.000959	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—ELMO1—primary biliary cirrhosis	7.42e-05	0.000935	CbGpPWpGaD
Duloxetine—SLC6A2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	7.32e-05	0.000921	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CXCL10—primary biliary cirrhosis	7.07e-05	0.000891	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CXCL9—primary biliary cirrhosis	6.97e-05	0.000877	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PDHX—primary biliary cirrhosis	6.93e-05	0.000873	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—AGT—primary biliary cirrhosis	6.92e-05	0.000871	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	6.77e-05	0.000852	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CCL5—primary biliary cirrhosis	6.71e-05	0.000844	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—OGDH—primary biliary cirrhosis	6.59e-05	0.00083	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—MMP9—primary biliary cirrhosis	6.52e-05	0.000821	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ABCB4—primary biliary cirrhosis	6.52e-05	0.000821	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—DLAT—primary biliary cirrhosis	6.52e-05	0.000821	CbGpPWpGaD
Duloxetine—SLC6A3—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	6.48e-05	0.000816	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—NFKB1—primary biliary cirrhosis	6.46e-05	0.000813	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—MMP3—primary biliary cirrhosis	6.45e-05	0.000812	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—ELMO1—primary biliary cirrhosis	6.45e-05	0.000812	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CXCL10—primary biliary cirrhosis	6.14e-05	0.000773	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCL5—primary biliary cirrhosis	6.09e-05	0.000767	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	5.94e-05	0.000748	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PDHX—primary biliary cirrhosis	5.87e-05	0.000739	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CCL5—primary biliary cirrhosis	5.82e-05	0.000733	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CXCL10—primary biliary cirrhosis	5.68e-05	0.000715	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—AGT—primary biliary cirrhosis	5.61e-05	0.000706	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—MMP3—primary biliary cirrhosis	5.6e-05	0.000705	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—DLAT—primary biliary cirrhosis	5.52e-05	0.000695	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ABCB4—primary biliary cirrhosis	5.52e-05	0.000695	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCL5—primary biliary cirrhosis	5.29e-05	0.000666	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—MMP3—primary biliary cirrhosis	5.18e-05	0.000652	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—TYK2—primary biliary cirrhosis	5.17e-05	0.000651	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—AGT—primary biliary cirrhosis	5.09e-05	0.000641	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	5.08e-05	0.00064	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCL5—primary biliary cirrhosis	4.89e-05	0.000615	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—AGT—primary biliary cirrhosis	4.87e-05	0.000613	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	4.73e-05	0.000596	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	4.53e-05	0.00057	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—AGT—primary biliary cirrhosis	4.42e-05	0.000557	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CXCL10—primary biliary cirrhosis	4.18e-05	0.000526	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HIF1A—primary biliary cirrhosis	4.1e-05	0.000516	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—AGT—primary biliary cirrhosis	4.09e-05	0.000515	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—NUP210—primary biliary cirrhosis	3.92e-05	0.000493	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—MMP3—primary biliary cirrhosis	3.81e-05	0.00048	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—TYK2—primary biliary cirrhosis	3.81e-05	0.00048	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ABCG2—primary biliary cirrhosis	3.64e-05	0.000459	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CXCL10—primary biliary cirrhosis	3.63e-05	0.000457	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CD80—primary biliary cirrhosis	3.62e-05	0.000456	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCL5—primary biliary cirrhosis	3.6e-05	0.000453	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	3.52e-05	0.000444	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	3.49e-05	0.000439	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—NUP210—primary biliary cirrhosis	3.32e-05	0.000418	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—MMP3—primary biliary cirrhosis	3.31e-05	0.000417	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—TYK2—primary biliary cirrhosis	3.31e-05	0.000417	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CTGF—primary biliary cirrhosis	3.12e-05	0.000393	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCL5—primary biliary cirrhosis	3.12e-05	0.000393	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—GOT2—primary biliary cirrhosis	3.1e-05	0.00039	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ABCG2—primary biliary cirrhosis	3.09e-05	0.000388	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—TYK2—primary biliary cirrhosis	3.06e-05	0.000385	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	3.03e-05	0.000381	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HIF1A—primary biliary cirrhosis	3.02e-05	0.00038	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—AGT—primary biliary cirrhosis	3.01e-05	0.000379	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	2.7e-05	0.000341	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—GGT1—primary biliary cirrhosis	2.67e-05	0.000337	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—GOT1—primary biliary cirrhosis	2.67e-05	0.000337	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CD80—primary biliary cirrhosis	2.67e-05	0.000336	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CTGF—primary biliary cirrhosis	2.65e-05	0.000333	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—GOT2—primary biliary cirrhosis	2.62e-05	0.00033	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.62e-05	0.00033	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—AGT—primary biliary cirrhosis	2.61e-05	0.000329	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—MMP9—primary biliary cirrhosis	2.41e-05	0.000303	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.38e-05	0.0003	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PPARGC1A—primary biliary cirrhosis	2.38e-05	0.000299	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CD80—primary biliary cirrhosis	2.32e-05	0.000291	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—GOT1—primary biliary cirrhosis	2.26e-05	0.000285	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—GGT1—primary biliary cirrhosis	2.26e-05	0.000285	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TYK2—primary biliary cirrhosis	2.25e-05	0.000283	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PPARGC1A—primary biliary cirrhosis	2.02e-05	0.000254	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TYK2—primary biliary cirrhosis	1.95e-05	0.000246	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—AGT—primary biliary cirrhosis	1.85e-05	0.000233	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—MMP9—primary biliary cirrhosis	1.77e-05	0.000223	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.75e-05	0.000221	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—AGT—primary biliary cirrhosis	1.57e-05	0.000198	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—MMP9—primary biliary cirrhosis	1.54e-05	0.000194	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.52e-05	0.000192	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ALB—primary biliary cirrhosis	1.42e-05	0.000179	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ALB—primary biliary cirrhosis	1.2e-05	0.000152	CbGpPWpGaD
